Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis

Overview

Journal Curr HIV Res

Publisher Bentham Science Publishers

Date 2016 Mar 25

PMID 27009099

Citations 10

Authors

Matias Jaureguiberry-Bravo

Rebecca Wilson

Loreto Carvallo

Joan W Berman

Affiliations

Soon will be listed here.

Abstract

Background: HIV-1 enters the CNS within two weeks after peripheral infection and results in chronic neuroinflammation that leads to HIV associated neurocognitive disorders (HAND) in more than 50% of infected people. HIV enters the CNS by transmigration of infected monocytes across the blood brain barrier. Intravenous drug abuse is a major risk factor for HIV-1 infection, and opioids have been shown to alter the progression and severity of HAND. Methadone and buprenorphine are opioid derivates that are used as opioid maintenance therapies. They are commonly used to treat opioid dependency in HIV infected substance abusers, but their effects on monocyte migration relevant to the development of cognitive impairment are not well characterized.

Conclusion: Here, we will discuss the effects of opioids and opioid maintenance therapies on the inflammatory functions of monocytes and macrophages that are related to the development of neuroinflammation in the context of HIV infection.

Citing Articles

Opioid abuse and SIV infection in non-human primates.

Deshetty U, Ray S, Singh S, Buch S, Periyasamy P J Neurovirol. 2023; 29(4):377-388.

PMID: 37418108 PMC: 10729652. DOI: 10.1007/s13365-023-01153-z.

Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction.

Takata F, Nakagawa S, Matsumoto J, Dohgu S Front Cell Neurosci. 2021; 15:661838.

PMID: 34588955 PMC: 8475767. DOI: 10.3389/fncel.2021.661838.

Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque model.

Acharya A, Olwenyi O, Thurman M, Pandey K, Morsey B, Lamberty B J Virol. 2020; 95(5).

PMID: 33328304 PMC: 8092838. DOI: 10.1128/JVI.01657-20.

Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Fitting S, McRae M, Hauser K J Neuroimmune Pharmacol. 2020; 15(4):584-627.

PMID: 32876803 PMC: 7463108. DOI: 10.1007/s11481-020-09941-8.

Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment.

Jaureguiberry-Bravo M, Kelschenbach J, Murphy A, Carvallo L, Hadas E, Tesfa L J Leukoc Biol. 2020; 109(3):675-681.

PMID: 32578908 PMC: 8525325. DOI: 10.1002/JLB.5AB0420-531R.

References

Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O, Nonnemacher M . Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis. J Neurovirol. 2011; 17(4):291-302. PMC: 3757547. DOI: 10.1007/s13365-011-0037-2. View

Grimm M, Ben-Baruch A, Taub D, Howard O, Wang J, Oppenheim J . Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci. 1998; 840:9-20. DOI: 10.1111/j.1749-6632.1998.tb09544.x. View

Amirshahrokhi K, Dehpour A, Hadjati J, Sotoudeh M, Ghazi-Khansari M . Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicol Appl Pharmacol. 2008; 232(1):119-24. DOI: 10.1016/j.taap.2008.06.020. View

Zajicova A, Wilczek H, Holan V . The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone. Folia Biol (Praha). 2004; 50(1):24-8. View

Ransohoff R . The chemokine system in neuroinflammation: an update. J Infect Dis. 2002; 186 Suppl 2:S152-6. DOI: 10.1086/344266. View

Steele A, Henderson E, Rogers T . Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology. 2003; 309(1):99-107. DOI: 10.1016/s0042-6822(03)00015-1. View

Peterson P, Gekker G, Brummitt C, Pentel P, Bullock M, Simpson M . Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J Infect Dis. 1989; 159(3):480-7. DOI: 10.1093/infdis/159.3.480. View

Sung S, Conry J . Role of buprenorphine in the management of heroin addiction. Ann Pharmacother. 2006; 40(3):501-5. DOI: 10.1345/aph.1G276. View

DElia M, Patenaude J, Hamelin C, Garrel D, Bernier J . No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters. Clin Immunol. 2003; 109(2):179-87. DOI: 10.1016/s1521-6616(03)00177-3. View

10.

Diaz T, Chu S, Byers Jr R, Hersh B, Conti L, Rietmeijer C . The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health. 1994; 84(12):1971-5. PMC: 1615366. DOI: 10.2105/ajph.84.12.1971. View

11.

Davis L, Hjelle B, Miller V, PALMER D, Llewellyn A, Merlin T . Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992; 42(9):1736-9. DOI: 10.1212/wnl.42.9.1736. View

12.

Eugenin E, Clements J, Zink M, Berman J . Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci. 2011; 31(26):9456-65. PMC: 3132881. DOI: 10.1523/JNEUROSCI.1460-11.2011. View

13.

Van Epps D, Saland L . Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol. 1984; 132(6):3046-53. View

14.

Przewlocki R, Hassan A, Lason W, Epplen C, Herz A, Stein C . Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 1992; 48(2):491-500. DOI: 10.1016/0306-4522(92)90509-z. View

15.

Bell J, Brettle R, Chiswick A, Simmonds P . HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain. 1998; 121 ( Pt 11):2043-52. DOI: 10.1093/brain/121.11.2043. View

16.

Guo C, Li Y, Tian S, Wang X, Douglas S, Ho W . Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med. 2002; 50(6):435-42. PMC: 4037869. DOI: 10.1136/jim-50-06-03. View

17.

Kreek M, Borg L, Ducat E, Ray B . Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis. 2010; 29(2):200-16. PMC: 2885886. DOI: 10.1080/10550881003684798. View

18.

Allen J, Wong H, Guyre P, Simon G, Wahl S . Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest. 1991; 87(5):1773-9. PMC: 295289. DOI: 10.1172/JCI115196. View

19.

Rogers T, Steele A, Howard O, Oppenheim J . Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann N Y Acad Sci. 2001; 917:19-28. DOI: 10.1111/j.1749-6632.2000.tb05369.x. View

20.

Williams D, Eugenin E, Calderon T, Berman J . Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol. 2012; 91(3):401-15. PMC: 3289493. DOI: 10.1189/jlb.0811394. View